1. Liu, Zhenchuan, Wang, Tingting, She, Yunlang, Chen, Chang, Zhou, Yongxin. 2021. N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. In Molecular cancer, 20, 105. doi:10.1186/s12943-021-01398-4. https://pubmed.ncbi.nlm.nih.gov/34416901/
2. Du, Yan, Hou, Shuang, Chen, Zhou, Li, Xin, Zhou, Wence. 2023. Comprehensive Analysis Identifies PKP3 Overexpression in Pancreatic Cancer Related to Unfavorable Prognosis. In Biomedicines, 11, . doi:10.3390/biomedicines11092472. https://pubmed.ncbi.nlm.nih.gov/37760912/
3. Müller, Lisa, Keil, René, Hatzfeld, Mechthild. 2023. Plakophilin 3 facilitates G1/S phase transition and enhances proliferation by capturing RB protein in the cytoplasm and promoting EGFR signaling. In Cell reports, 42, 112031. doi:10.1016/j.celrep.2023.112031. https://pubmed.ncbi.nlm.nih.gov/36689330/
4. Qian, Hua, Yuan, Donglan, Bao, Jingjing, Sheng, Haihui, Yu, Hong. . Increased expression of plakophilin 3 is associated with poor prognosis in ovarian cancer. In Medicine, 98, e14608. doi:10.1097/MD.0000000000014608. https://pubmed.ncbi.nlm.nih.gov/30855445/
5. Sklyarova, Tatyana, van Hengel, Jolanda, Van Wonterghem, Elien, van Roy, Frans, Vandenbroucke, Roosmarijn E. 2015. Hematopoietic plakophilin-3 regulates acute tissue-specific and systemic inflammation in mice. In European journal of immunology, 45, 2898-910. doi:10.1002/eji.201445440. https://pubmed.ncbi.nlm.nih.gov/26173741/
6. Basu, Srikanta, Chaudhary, Nazia, Shah, Sanket, Gupta, Sanjay, Dalal, Sorab N. 2018. Plakophilin3 loss leads to an increase in lipocalin2 expression, which is required for tumour formation. In Experimental cell research, 369, 251-265. doi:10.1016/j.yexcr.2018.05.026. https://pubmed.ncbi.nlm.nih.gov/29803740/
智鼠故事 
